Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel S Warren

Showing results (31-40 of 58) with videos related to

Pageof 6
Sort By:
Plos One|April 30, 2015
Systemic Delivery of scAAV8-Encoded MiR-29a Ameliorates Hepatic Fibrosis in Carbon Tetrachloride-Treated MiceMatthew K Knabel, Kalyani Ramachandran, Sunil Karhadkar, et al.
The New England Journal of Medicine|July 29, 2011
Desensitization in HLA-incompatible kidney recipients and survivalRobert A Montgomery, Bonnie E Lonze, Karen E King, et al.
Transplantation|April 23, 2009
ABO incompatible renal transplantation: a paradigm ready for broad implementationRobert A Montgomery, Jayme E Locke, Karen E King, et al.
Science Translational Medicine|July 19, 2019
Calpain 9 as a therapeutic target in TGFβ-induced mesenchymal transition and fibrosisDavid H Kim, James D Beckett, Varun Nagpal, et al.
Transplantation|March 7, 2022
Effect of Mycophenolate Mofetil Dosing on Antibody Response to SARS-CoV-2 Vaccination in Heart and Lung Transplant RecipientsJonathan Mitchell, Teresa P-Y Chiang, Jennifer L Alejo, et al.
Transplantation|November 18, 2021
Antibody Response to an mRNA SARS-CoV-2 Vaccine Following Initial Vaccination With Ad.26.COV2.S in Solid Organ Transplant Recipients: A Case SeriesAmy Chang, Jennifer L Alejo, Aura T Abedon, et al.
Clinical Transplantation|September 8, 2022
Antibody response to a third dose of SARS-CoV-2 vaccine in heart and lung transplant recipientsJennifer L Alejo, Jessica M Ruck, Teresa P Y Chiang, et al.
Clinical Transplantation|November 28, 2022
6-month antibody kinetics and durability after four doses of a SARS-CoV-2 vaccine in solid organ transplant recipientsJonathan Mitchell, Teresa Py Chiang, Jennifer L Alejo, et al.
Transplantation|January 23, 2022
Six-month Antibody Kinetics and Durability After 3 Doses of SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients: A Case SeriesAura T Abedon, Jennifer L Alejo, Jake D Kim, et al.
Clinical Transplantation|July 13, 2022
Immunogenicity of Ad26.COV2.S prime and two subsequent doses of mRNA SARS-CoV-2 vaccines in solid organ transplant recipients: A case seriesAmy Chang, Jonathan Mitchell, Jennifer L Alejo, et al.
Pageof 6

Showing results (31-40 of 58) with videos related to

Sort By:
Pageof 6
Plos One|April 30, 2015
Systemic Delivery of scAAV8-Encoded MiR-29a Ameliorates Hepatic Fibrosis in Carbon Tetrachloride-Treated MiceMatthew K Knabel, Kalyani Ramachandran, Sunil Karhadkar, et al.
The New England Journal of Medicine|July 29, 2011
Desensitization in HLA-incompatible kidney recipients and survivalRobert A Montgomery, Bonnie E Lonze, Karen E King, et al.
Transplantation|April 23, 2009
ABO incompatible renal transplantation: a paradigm ready for broad implementationRobert A Montgomery, Jayme E Locke, Karen E King, et al.
Science Translational Medicine|July 19, 2019
Calpain 9 as a therapeutic target in TGFβ-induced mesenchymal transition and fibrosisDavid H Kim, James D Beckett, Varun Nagpal, et al.
Transplantation|March 7, 2022
Effect of Mycophenolate Mofetil Dosing on Antibody Response to SARS-CoV-2 Vaccination in Heart and Lung Transplant RecipientsJonathan Mitchell, Teresa P-Y Chiang, Jennifer L Alejo, et al.
Transplantation|November 18, 2021
Antibody Response to an mRNA SARS-CoV-2 Vaccine Following Initial Vaccination With Ad.26.COV2.S in Solid Organ Transplant Recipients: A Case SeriesAmy Chang, Jennifer L Alejo, Aura T Abedon, et al.
Clinical Transplantation|September 8, 2022
Antibody response to a third dose of SARS-CoV-2 vaccine in heart and lung transplant recipientsJennifer L Alejo, Jessica M Ruck, Teresa P Y Chiang, et al.
Clinical Transplantation|November 28, 2022
6-month antibody kinetics and durability after four doses of a SARS-CoV-2 vaccine in solid organ transplant recipientsJonathan Mitchell, Teresa Py Chiang, Jennifer L Alejo, et al.
Transplantation|January 23, 2022
Six-month Antibody Kinetics and Durability After 3 Doses of SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients: A Case SeriesAura T Abedon, Jennifer L Alejo, Jake D Kim, et al.
Clinical Transplantation|July 13, 2022
Immunogenicity of Ad26.COV2.S prime and two subsequent doses of mRNA SARS-CoV-2 vaccines in solid organ transplant recipients: A case seriesAmy Chang, Jonathan Mitchell, Jennifer L Alejo, et al.
Pageof 6